# Filtricine, Inc.: Research, Sunnyvale, United States

> Filtricine, Inc.: Filtricine, Inc. is a clinical-stage biotechnology company located in the San Francisco Bay Area. Based in Sunnyvale, United States.

Source: https://millionrounds.com/startup/filtricine-inc (Millionrounds; every figure on the page links to its filing or article)

United States · [Research startup](https://millionrounds.com/companies)

# Filtricine, Inc.

Filtricine, Inc. is a clinical-stage biotechnology company located in the San Francisco Bay Area.

Funding reported Last round: Seed

Research Sunnyvale, United States

Company summary

- **Founded:** 2017 9 years old
- **Team:** 5 1 to 10 people
- **Funding reported:** $5.3M in dollars
- **Last round:** Seed Aug 2022

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Filtricine, Inc. has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Filtricine, Inc.

Filtricine, Inc. is a clinical-stage biotechnology company located in the San Francisco Bay Area.

It focuses on developing innovative food-based products aimed at cancer care and disease control. The company employs a nutrition-based approach known as Targeted Nutrients Deprivation, which is designed to support patients while targeting cancer cells. The main product offered by Filtricine is Tality, a proprietary medical food and meal-replacement regimen specifically for cancer patients. Tality is currently being investigated in clinical studies and has been utilized in a Stanford-sponsored prostate cancer clinical trial. Filtricine aims to help patients maintain proper nutrition during their treatment and has plans to expand its product offerings to address other common diseases in the future. Filtricine's target audience includes cancer patients, hospitals, clinics, and healthcare institutions that may use or distribute its products. The company is dedicated to serving the North American cancer-care market and is committed to improving patient outcomes through its nutritional solutions.

## What company datasets say Filtricine, Inc. raised

Funding, as reported

Reported in all **$5.3M** in dollars

Rounds **6**

Last round **Seed**

Last round date **Aug 2022**

Investors listed **10**

## Founders and team

From Filtricine, Inc.'s own website: 3 founders, 6 on the team.

**Dr. Grace Xiaolu Yang** COO, VP of Research & Co-founder

**Dr. Joseph V Rodricks** Founding Principal

**Dr. Xiyan Li** Co-founder

- **Alister Thomson** Director
- **Brad Barnes** Director
- **Dr. Mike P Snyder** Chair of Genetics
- **Dr. Wei Jiang** Senior Director
- **Jeff Depew** Board Director & Committee Chair
- **Mike Partsuf** Senior Food Scientist

## On 2 portfolio pages

Investors who name them

- [Bluestein Ventures](https://millionrounds.com/fund/bluestein-ventures)
- [Bluestein & Associates](https://millionrounds.com/fund/bluestein-and-associates)

Each firm lists Filtricine, Inc. on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

health care venture-backed biotech tnd diet precision nutrition biotechnology research cancer patient support dialysis modification for nutrient depletion cancer prevention non-essential amino acids deprivation of non-essential amino acids clinical investigation cancer cell starvation targeted nutrients deprivation metabolism research stanford university nutritional therapy

Built with from their website

Google Maps Amazon CloudFront Google Workspace CloudFlare Viewport Meta Hostgator Webflow Hosting Google Meet CloudFlare CDN Mobile Friendly

+8 more

Open Graph jQuery Cloudflare DNS HTTP/3 Google Maps (Non Paid Users) Amazon AWS HSTS Webflow

- **Sector:** Research
- **Industry code:** NAICS 62139, 541714, 311999, SIC 2834, 8731, 2099
- **Region:** California
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/filtricine)

## Research in United States

Startups like it

- [**OpenAI** San Francisco · founded 2011 *Raised*](https://millionrounds.com/company/openai)
- [**Retro Biosciences** Redwood City · founded 2021 *Raised*](https://millionrounds.com/company/retro-biosciences)
- [**NewLimit** South San Francisco · founded 2022 *Raised*](https://millionrounds.com/company/newlimit)
- [**Pathos** New York · founded 2022 *Raised*](https://millionrounds.com/company/pathos)
- [**Colossal Biosciences** Dallas · founded 2021 *Raised*](https://millionrounds.com/company/colossal-biosciences)
- [**Oratomic** South Pasadena *Raised*](https://millionrounds.com/company/oratomic)
- [**Beeline Medicines** Stamford · founded 2025 *Raised*](https://millionrounds.com/company/beeline-medicines)
- [**Element Biosciences** San Diego · founded 2017 *Raised*](https://millionrounds.com/company/element-biosciences)

## Is this your company?

Add your raise, your deck and your story, and put Filtricine, Inc. in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)